Eastern Bankshares, Inc. Announces Newly Appointed Members To Its Board of Directors

In This Article:

BOSTON, July 01, 2024--(BUSINESS WIRE)--Eastern Bankshares, Inc. ("Eastern") (NASDAQ Global Select Market: EBC), the stock holding company for Eastern Bank, announced today the appointment of four members of Cambridge Bancorp’s (NASDAQ: CATC) ("Cambridge") Board of Directors to the Eastern and Eastern Bank Boards of Directors (together, the "Eastern Boards of Directors" or the "Eastern Boards") effective upon the closing of the companies’ pending Merger (the "Merger").

As previously announced on September 19, 2023, upon closing of the Merger, Denis Sheahan, Chairman, President and CEO of Cambridge, will become the CEO of Eastern and will join the Eastern Boards of Directors, and three Cambridge directors will be appointed to the Eastern Boards. Eastern Chief Executive Officer and Chair of the Eastern Boards, Bob Rivers, will serve as Executive Chair and Chair of the Eastern Boards. The Merger is expected to close on or about July 12, 2024.

The three Cambridge directors appointed to the Eastern Boards of Directors are industry leaders with extensive experience in banking and professional services, real estate, risk management and corporate governance, and include:

  • Leon A. Palandjian

  • Cathleen A. Schmidt

  • Andy S. Zelleke

"We are pleased to announce the appointment of Denis Sheahan, Leon Palandjian, Cathy Schmidt, and Andy Zelleke to Eastern’s Boards of Directors, and look forward to benefitting from their guidance and insights," said Bob Rivers, Chief Executive Officer and Chair of the Eastern Boards. "They are thoughtful and highly respected leaders who understand our commitment to serving our shareholders, customers, colleagues and local communities. Their expertise will help drive greater value and innovation as our two organizations come together to create Greater Boston’s leading local bank and the largest bank-owned independent investment advisor in Massachusetts."

About the Directors

Leon A. Palandjian. Dr. Palandjian is the Chief Risk Officer of Intercontinental Real Estate Corporation, a national real estate investment, development and management firm headquartered in Boston, MA. His investment experience spans venture capital and private and public equity in the life sciences and real estate sectors. Dr. Palandjian has served as a Director of Cambridge Bancorp and Cambridge Trust since 2006, and was Lead Director from 2014 until January 2017. He served as a Member of the Board of Trustees of the Mount Auburn Hospital between 2003 – 2020, and currently serves on the Advisory Board of the McCance Center for Brain Health at Mass General Brigham Hospital. He received a B.A. degree from Harvard College, and an M.D. degree from Harvard Medical School. He is a CFA Charterholder.